The Malaysian Reserve

DXCM Announcement: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit

Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the firm ...
Medical Device and Diagnostic Industry (MD+DI)

Dexcom Faces G6 Recall

Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...

DexCom, Inc. (DXCM) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DXCM Investors of Securities Fraud Class Action Lawsuit

Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the firm directly to acquire more information. CLICK HERE TO SIGN UP FOR THE CASE OR GO ...
Le Lézard

The Gross Law Firm Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 26, 2025 - DXCM

Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plai ...
Le Lézard

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") of a class action securities lawsuit.

Shareholders That Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class Action - DXCM

Levi & Korsinsky, LLP notifies investors in DexCom, Inc. (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DexCom investors who ...
The National Law Review

FriskaAi and Dexcom Enter CGM Data Integration Agreement

ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 ...
Mena FN

DEXCOM CLASS ACTION LAWSUIT: Dexcom, Inc. (NASDAQ:DXCM) Investors With Losses Are Notified Of The Upcoming December 26 Court Deadline Contact BFA Law

If you invested in DexCom, you are encouraged to obtain additional information by visiting: Investors have until December 26, 2025, to ask the Court to be appointed to lead the case. The complaint ...
The Malaysian Reserve

DXCM Stockholders With Large Losses Should Contact Robbins LLP for Information About Leading the Dexcom, Inc. Securities Fraud Class Action

The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Dexcom, Inc. securities during the class period because the Company ...
TMCnet

Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against Dexcom, Inc.

Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action in the U.S. District Court for the Southern District of New York alleging violations ...

1 Spectacular Growth Stock Down 20% to Buy Right Now, According to Wall Street

Since last year, DexCom ( DXCM +5.54%) has faced a series of issues that have sunk its stock price. The medical device ...
TMCnet

Tandem Mobi Receives FDA Clearance for Use with Android Smartphones

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Android version ...